InflaRx N.V.
Biotechnology ResearchView the employees at
InflaRx N.V.-
-
Munich, Bavaria, Germany
-
Rising Star
Sandra Medem Drug Safety Associate-
Munich, Bavaria, Germany
-
Rising Star
Dineshan Sivaselvarajah Drug Safety Manager - Pharmacovigilance-
Rising Star
Ulrike Redlich Senior Manager, Global Clinical Trial Supplies-
Rising Star
James Dickinson Head of Clinical Pharmacology and Pharmacokinetics at InflaRx N.V.-
Top 10%
Overview
InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. Complement C5a is a powerful inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. InflaRx was founded in 2007 and the group has offices and subsidiaries in Jena and Munich, Germany, as well as Ann Arbor, MI USA.
-